Hedge Fund - Renaissance Technologies
Corcept Therapeutics Inc (CORT)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $701,657,001 | 1.06% | 6,143,031 | $60.87 |
| 2 | 2024 - Q4 (2024-12-31) | $312,347,555 | 0.46% | 6,198,602 | $52.40 |
| 3 | 2024 - Q3 (2024-09-30) | $301,236,613 | 0.45% | 6,509,002 | $35.53 |
| 4 | 2024 - Q2 (2024-06-30) | $224,589,432 | 0.38% | 6,912,571 | $27.39 |
| 5 | 2024 - Q1 (2024-03-31) | $179,312,000 | 0.28% | 7,118,371 | $23.63 |
| 6 | 2023 - Q4 (2023-12-31) | $218,456,000 | 0.33% | 6,725,871 | $27.46 |
| 7 | 2023 - Q3 (2023-09-30) | $180,222,000 | 0.3% | 6,614,871 | $28.94 |
| 8 | 2023 - Q2 (2023-06-30) | $149,074,000 | 0.21% | 6,699,971 | $23.02 |
| 9 | 2023 - Q1 (2023-03-31) | $147,030,000 | 0.19% | 6,788,069 | $21.92 |
| 10 | 2022 - Q4 (2022-12-31) | $148,037,000 | 0.2% | 7,288,871 | $25.07 |
| 11 | 2022 - Q3 (2022-09-30) | $184,543,000 | 0.26% | 7,197,471 | $26.76 |
| 12 | 2022 - Q2 (2022-06-30) | $186,289,000 | 0.22% | 7,833,871 | $21.79 |
| 13 | 2022 - Q1 (2022-03-31) | $174,992,000 | 0.2% | 7,770,516 | $21.27 |
| 14 | 2021 - Q4 (2021-12-31) | $158,868,000 | 0.19% | 8,023,616 | $20.29 |
| 15 | 2021 - Q3 (2021-09-30) | $162,318,000 | 0.2% | 8,247,841 | $20.93 |
| 16 | 2021 - Q2 (2021-06-30) | $187,488,000 | 0.23% | 8,522,196 | $22.25 |
| 17 | 2021 - Q1 (2021-03-31) | $208,729,000 | 0.25% | 8,773,796 | $26.70 |
| 18 | 2020 - Q4 (2020-12-31) | $244,374,000 | 0.26% | 9,341,496 | $21.07 |
| 19 | 2020 - Q3 (2020-09-30) | $167,192,000 | 0.16% | 9,605,996 | $15.94 |
| 20 | 2020 - Q2 (2020-06-30) | $150,034,000 | 0.12% | 8,919,996 | $14.05 |
| 21 | 2020 - Q1 (2020-03-31) | $98,721,000 | 0.09% | 8,302,841 | $12.37 |
| 22 | 2019 - Q4 (2019-12-31) | $93,995,000 | 0.07% | 7,768,214 | $13.92 |
| 23 | 2019 - Q3 (2019-09-30) | $92,220,000 | 0.07% | 6,524,209 | $12.29 |
| 24 | 2019 - Q2 (2019-06-30) | $62,334,000 | 0.05% | 5,590,509 | $11.14 |
| 25 | 2019 - Q1 (2019-03-31) | $59,379,000 | 0.05% | 5,057,809 | $12.43 |
| 26 | 2018 - Q4 (2018-12-31) | $62,087,000 | 0.06% | 4,647,209 | $13.22 |
| 27 | 2018 - Q3 (2018-09-30) | $61,907,000 | 0.06% | 4,415,600 | $13.97 |
| 28 | 2018 - Q2 (2018-06-30) | $68,310,000 | 0.07% | 4,345,400 | $17.40 |
| 29 | 2018 - Q1 (2018-03-31) | $78,935,000 | 0.08% | 4,798,500 | $18.53 |
| 30 | 2017 - Q4 (2017-12-31) | $89,478,000 | 0.09% | 4,954,500 | $18.11 |
| 31 | 2017 - Q3 (2017-09-30) | $70,826,000 | 0.08% | 3,669,755 | $14.91 |
| 32 | 2017 - Q2 (2017-06-30) | $31,664,000 | 0.04% | 2,683,400 | $10.87 |
| 33 | 2017 - Q1 (2017-03-31) | $20,369,000 | 0.02% | 1,858,500 | $8.78 |
| 34 | 2016 - Q4 (2016-12-31) | $10,944,000 | 0.01% | 1,507,500 | $7.84 |
| 35 | 2016 - Q3 (2016-09-30) | $3,640,000 | 0% | 560,000 | $5.82 |
| 36 | 2016 - Q2 (2016-06-30) | $1,696,000 | 0% | 310,600 | $5.20 |
| 37 | 2016 - Q1 (2016-03-31) | $896,000 | 0% | 191,400 | $3.90 |
| 38 | 2015 - Q4 (2015-12-31) | $2,293,000 | 0% | 460,400 | $4.51 |
| 39 | 2015 - Q3 (2015-09-30) | $1,700,000 | 0% | 452,200 | $5.07 |
| 40 | 2015 - Q2 (2015-06-30) | $3,015,000 | 0% | 501,614 | $6.13 |
| 41 | 2015 - Q1 (2015-03-31) | $310,000 | 0% | 55,400 | $3.62 |
The displayed share prices are average quarterly stock market prices.